Get started Log in

ALZ — Alzinova AB Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapNeutral

Market Cap
SEK84.45m
Enterprise Value
SEK73.87m
Revenue

Brief: Alzinova Gets Positive Response From European Medicines Agency EMA
26/09/2023 07:10
Brief: Alzinova Partners With Polypeptide
25/08/2023 07:19
Brief: Alzinova Q2 EPS at SEK -0.1
17/08/2023 07:54
Brief: Alzinova Progresses Following Positive Pre-Ind Meeting With FDA
09/08/2023 07:14
Brief: Alzinova Submits Request For Pre-IND Meeting With FDA, Applies For EMA Scientific Advice
13/06/2023 07:21
Brief: Alzinova Starts Extension Part Of Phase 1b Study With ALZ-101
29/05/2023 12:09
Brief: Alzinova Q1 Loss After Financial Items Widens To SEK 4.3 Mln
17/05/2023 07:08
Brief: Alzinova Q1 EPS at SEK -0.09
17/05/2023 07:00
Brief: Alzinova Chief Medical Officer To Leave Company
27/04/2023 13:29
Brief: Alzinova Files Patent Application For Alz-201 Antibody
21/03/2023 07:06
Brief: Alzinova: New Positive Safety Review Of Phase 1B Study For ALZ-101 Vaccine
16/03/2023 07:15
Brief: Alzinova Board Proposes No Dividends To Be Paid For 2022
23/02/2023 07:18
Brief: Alzinova Q3 Loss After Financial Items Widens To SEK 2.8 Mln
01/11/2022 07:15
Brief: Alzinova Announces New Positive Safety Review Of Its Phase 1B Study In Alzheimer's Disease
07/09/2022 07:11
Brief: Alzinova Q2 Loss At SEK 3.3 Mln
25/08/2022 07:12
Brief: Alzinova Announces Outcome Of Rights Issue
15/06/2022 07:05
Brief: Alzinova Initiates Development Of A Stable Cell Line To Prepare The Monoclonal Antibody Alz-201 For Alzheimer's Clinical Trials
24/05/2022 19:10
Brief: Alzinova Announces Positive Safety Review And Continuation Of Its Phase 1B Study In Alzheimer's Disease
28/04/2022 07:18
Brief: Alzinova Resolves On Rights Issue Of Units Of SEK 42.5 Mln
19/04/2022 07:33
Brief: Alzinova Q1 Pretax Loss Widens To SEK 2.3 Million
19/04/2022 07:13